V.і. Іgnatieva

V.і. Іgnatieva

Auto-generated profile, based on publicly available information

V.і. Іgnatieva

SI “National scientific center of phthisiology, pulmonology and allergology named after F.G. Yanovsky of the NAMS of Ukraine”, Kyiv, Ukraine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2020 in Infusion & Chemotherapy
Verified
Journal Article
Open access
PDF file
МGМ.і. Gumeniuk
М.і. Gumeniuk
VІV.і. Іgnatieva
V.і. Іgnatieva
МLМ.і. Lynnyk
М.і. Lynnyk
GGG.L. Gumeniuk
G.L. Gumeniuk
VSV.а. Svyatnenko
V.а. Svyatnenko
MPM.G. Palivoda
M.G. Palivoda
BACKGROUND. At present, the overall picture of coronavirus disease (COVID-19), the causative agent of which is SARS- CoV-2, consists of hundreds of reports and articles in scientific journals, where doctors from around the world share their experience in diagnosing and treating patients. OBJECTIVE. To analyze the informativeness of imaging methods in the diagnosis of community-acquired pneumonia of viral etiology (COVID-19). MATERIALS AND METHODS. We used test access to such full-text and abstract databases: a single package of the information database EBSCO; the largest abstract and citation database of peer-reviewed literature Scopus; Google Scholar; MEDLINE with Full Text; MEDLINE Complete; Dyna Med Plus; EBSCO eBooks Clinical Collection; Web of Science Core Collection WoS (CC); SCIE (Science Citation Index Expanded); SSCI (Social Science Citation Index); AHCI (Artand Humanities Citation Index). RESULTS AND DISCUSSION. Modern imaging methods that can be used in the diagnosis and monitoring of viral etiology (COVID-19) community-acquired pneumonia include: chest radiography (CR), computed tomography (CT) of chest and ultrasound (US). The analysis allowed to determine the typical criteria for the diagnosis of inflammatory changes of chest of viral etiology (COVID-19) according to CT and to identify radiological criteria for the severity of the disease. In-patient CR and US are recommended for use in critically ill patients who are in intensive care units, when it is impossible to transport patients. CONCLUSIONS. CT is an objective and most informative research method in the diagnosis of COVID-19 pneumonia.

29 June 2021 in Infusion & Chemotherapy
Verified
Journal Article
Open access
PDF file
МLМ.і. Lynnyk
М.і. Lynnyk
VІV.і. Іgnatieva
V.і. Іgnatieva
GGG.L. Gumeniuk
G.L. Gumeniuk
VSV.а. Svyatnenko
V.а. Svyatnenko
OTO.R. Tarasenko
O.R. Tarasenko
OBO.L. Bororova
O.L. Bororova
BACKGROUND. To date, radiological criteria for the diagnosis of viral pneumonia associated with SARS-CoV-2 have been established, and treatment regimens for patients depending on the severity of coronavirus disease (COVID-19) have been developed for both outpatient and inpatient settings. Many patients, regardless of the form and severity of the coronavirus infection, suffer from a range of symptoms for weeks or even months that reduce their quality of life. Therefore, the diagnostics of complicated course of community-acquired pneumonia of viral etiology (COVID-19) via using computed tomography (CT) of the chest becomes relevant. OBJECT. To diagnose a complicated course of community-acquired pneumonia of viral etiology (COVID-19) according to CT of the chest. MATERIALS AND METHODS. A group of patients referred for treatment to the National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine with complications of pneumonia from other medical institutions where they were treated for community-acquired pneumonia of viral etiology (COVID-19) 2-3 months ago. Chest CT of 20 patients (12 men and 8 women aged from 24 to 66 years) were analyzed. All patients complained of shortness of breath, cough, lack of significant improvement in general condition after discharge from the hospital. RESULTS AND DISCUSSION. Typical complications of community-acquired pneumonia of viral etiology (COVID-19) were determined by CT: 10 % of patients showed gradual progression of viral pneumonia (numerous opacities were identified as “ground glass”, consolidation and the “crazy paving” symptom); 15 % – signs of thrombosis of the pulmonary arteries branches; 25 % – exacerbation of chronic obstructive pulmonary disease with preservation of signs of bilateral polysegmental viral pneumonia; 20 % – exacerbation of asthma with signs of bilateral polysegmental viral pneumonia in the regression phase; 30 % – bullous pulmonary emphysema (“vanishing lung syndrome”). CONCLUSIONS. Typical complications of pneumonia of viral etiology (COVID-19) indicate that the inflammatory process does not end after inpatient treatment and the presence of a negative PCR test, and patients need further careful monitoring and correction of treatment. CT is an objective and most informative diagnostic method of complicated community-acquired pneumonia of viral etiology (COVID-19).

28 December 2022 in Infusion & Chemotherapy
Verified
Journal Article
Open access
PDF file
ОYО.к. Yakovenko
О.к. Yakovenko
МLМ.і. Lynnyk
М.і. Lynnyk
VІV.і. Іgnatieva
V.і. Іgnatieva
GGG.L. Gumeniuk
G.L. Gumeniuk
SOS.G. Opimakh
S.G. Opimakh
SMS.M. Moskalenko
S.M. Moskalenko
BACKGROUND. The mechanism of development of post-COVID syndrome is not fully understood. Long-term retention of complaints in patients is associated with long-term persistence of the virus, hyperinflammatory response of the body, as well as with the peculiarities of the patient’s cellular and humoral immunity. Secondary infectious complications in the post-COVID period are due not only to the ability of the SARS-CoV-2 virus to damage erythrocytes and attack the red bone marrow in the acute phase of the disease. It has been proven that the SARS-CoV-2 virus leads to the disappearance of white pulp cells in the spleen, the tissue where cells of the immune response, in particular T- and B-lymphocytes responsible for infectious immunity, mature. OBJECTIVE. To investigate the frequency of secondary infectious complications of the respiratory tract and lungs in patients with post-COVID syndrome who underwent inpatient treatment. MATERIALS AND METHODS. Clinical, laboratory and radiological data of 90 patients with post-COVID syndrome who were undergoing inpatient treatment in the clinical departments of the SI “National institute of phthisiology and pulmonology named after F.G. Yanovsky of the NAMS of Ukraine”. The diagnosis of coronavirus disease (COVID-19) was established in accordance with the current national protocol for the treatment. Computed tomography (CT) of the chest organs was performed on the Aquilion TSX-101A scanner (Toshiba, Japan). RESULTS AND DISCUSSION. Complications of COVID-19 were determined according to the clinical and functional, laboratory examination and CT scan of the chest. Some patients had two or more complications at the same time. Patients with post-COVID syndrome were most often hospitalized for progression or slight positive dynamics of the pathological process of the respiratory tract and lungs, disappearing lung syndrome, fibrotic changes in the lungs, exacerbation of bronchoobstructive lung diseases and infectious complications. The latter were observed most often – in 53,3 % of patients. Fungal and bacterial complications occurred secondarily, mainly in patients with disappearing lung syndrome, in places where cystlike cavities were formed. The most common concomitant diseases in patients with post-COVID syndrome were cardiovascular diseases and diabetes. CONCLUSIONS. The proportion of infectious complications of the respiratory tract and lungs in patients with post-COVID syndrome, who are indicated for inpatient treatment in the pulmonology department, is 53.3 %. The most frequent causes of infectious complications of the respiratory tract and lungs in patients with post-COVID syndrome are the reactivation of the Epstein – Barr virus infection – in 30.0 %, which in 2.2 % of patients is combined with the reactivation of the hepatitis C virus, and bacterial infections – in 15.6 %. Aspergillosis and mucormycosis occur in 1.1 and 3.3 % of patients respectively.

29 June 2021 in Infusion & Chemotherapy
Verified
Journal Article
Open access
PDF file
МLМ.і. Lynnyk
М.і. Lynnyk
VІV.і. Іgnatieva
V.і. Іgnatieva
GGG.L. Gumeniuk
G.L. Gumeniuk
OTO.R. Tarasenko
O.R. Tarasenko
SOS.H. Opimakh
S.H. Opimakh
NVN.а. Vlasova
N.а. Vlasova
BACKGROUND. In a pandemic, when the etiotropic therapy of SARS-CoV-2 has not yet been developed, a comprehensive individual syndrome-pathogenetic approach to the treatment of patients with community-acquired pneumonia of viral etiology (COVID-19) is extremely important. The search for new commonly available drugs that can affect the inhibition of the cytokine storm, eliminate endothelial dysfunction and accelerate reparative processes in the lungs is relevant. At the same time the parenteral way of administration of the drugs provides the maximum bioavailability. OBJECT. To evaluate the treatment efficacy in the patients with viral etiology community-acquired pneumonia (COVID-19) with the use of syndrome-pathogenetic small volume infusion therapy according to computed tomography (CT) data. MATERIALS AND METHODS. We examined 12 patients (9 men and 3 women aged 18 to 62 years) with viral etiology community-acquired pneumonia (COVID-19), who were appointed for the treatment to the SI “National institute of phthisiology and pulmonology named after F.G. Yanovsky of the NAMS of Ukraine” in the acute period of the disease. 10 patients (8 men and 2 women aged 21 to 57 years) were referred to the institute from other medical institutions, where they were treated for viral etiology community-acquired pneumonia (COVID-19) 2-3 months ago. In addition to standard therapy all patients were additionally prescribed small volume infusion therapy 1-2 times a day for 10 days: Reosorbilact intravenous infusion 200 ml per day; Xavron (edaravon) 30 mg, which was diluted in 100 ml of saline, was administered intravenously; Tivorel (L-arginine and L-carnitine) intravenous infusion 100 ml per day. CT of the chest was performed on a scanner Aquilion TSX-101A (Toshiba, Japan) followed by comparative analysis. RESULTS AND DISCUSSION. Prior to treatment, patients with the viral etiology community-acquired pneumonia (COVID-19) had a systemic inflammatory process in both the acute and post-COVID-19 periods, which according to chest CT showed the same radiological symptoms: the presence of “ground-glass” and consolidation. Lesions of the lung parenchyma ranged from 30 to 60 %. After the course of treatment, all patients had a positive clinical effect, which was confirmed by positive radiological dynamics. At the same time, complete regression of pathological changes in the lungs was observed in 50 % of the patients with acute COVID-19 and in 40 % of the patients with post-COVID-19 syndrome. CONCLUSIONS. In the acute period of coronavirus infection when the patient is admitted to the hospital, it is advisable to additional use of the syndrome-pathogenetic treatment with such drugs: edaravon, a fixed combination of L-arginine and L-carnitine, hyperosmolar crystalloid solution in the regimen of small volume infusion therapy. This therapy can be used for patients in the post-COVID-19 period, when clinical symptoms, laboratory parameters of systemic inflammation, as well as characteristic pathological changes on chest CT present.

27 December 2021 in Infusion & Chemotherapy
Verified
Journal Article
Open access
PDF file
МLМ.і. Lynnyk
М.і. Lynnyk
ІLІ.V. Liskina
І.V. Liskina
МGМ.і. Gumeniuk
М.і. Gumeniuk
VІV.і. Іgnatieva
V.і. Іgnatieva
GGG.L. Gumeniuk
G.L. Gumeniuk
VIV.Y. Ivashchenko
V.Y. Ivashchenko
BACKGROUND. In the third wave of the pandemic, the coronavirus disease 2019 (COVID-19) was more aggressive. The available information on the pathogenesis of respiratory failure was supplemented with new data. Up-date information about the respiratory failure pathogenesis was acquired. It has been shown that the SARS-CoV-2 virus leads to disappearance of white pulp cells in the spleen. In this tissue immune cells mature and differentiate, among others T- and B-lymphocytes, which are responsible for premunition. The study of the structure and function of the spleen has become even more urgent. Some authors note a change in the size of the spleen during ultrasonography and chest computed tomography (CT), which correlate with indicators of the pneumonia“s severity. The study of the structure and function of the spleen has become even more urgent. OBJECTIVE. To study is to evaluate changes in the structure of solid organs (lungs, liver and spleen) in patients with a complicated community-acquired viral pneumonia COVID-19 by means of software digital processing of CT scan data and their comparison with pathomorphological changes. MATERIALS AND METHODS. The analysis of CT data in patients with a complicated community-acquired viral pneumonia COVID-19, who were treated at the SI “National institute of phthisiology and pulmonology named. F.G. Yanovsky of the NAMS of Ukraine”. CT WGC was performed on an Aquilion TSX-101A «Tochiba» scanner (Japan), followed by digital software processing of CT images using the Dragonfly software. Histological preparations were obtained as a result of traditional alcoholic histological tracing of tissue samples, embedded in paraffin blocks. To obtain micrographs, an Olympus BX51 microscope was used with an Olympus DP73 digital camera and a CellSens computer program for image processing. RESULTS AND DISCUSSION. The obtained results of digital software processing of CT images clearly correlate with autopsy histological examination of tissues of the same solid organs. Changes in the structure of the spleen occur earlier than in other solid organs, which gives reason to use these changes for diagnostic purposes. Digital processing of CT images of the spleen allows determining the severity of the disease, predicting its further course and evaluating the effectiveness of treatment. CONCLUSIONS. In patients with a complicated viral (COVID-19) community-acquired pneumonia changes (which can be determined by digital software processing of CT data) in the structure of solid organs, especially in lungs and spleen, were observed and they correlate with pathomorphological changes.

28 June 2025 in Infusion & Chemotherapy
Verified
Journal Article
Open access
PDF file
МLМ.і. Lynnyk
М.і. Lynnyk
VІV.і. Іgnatieva
V.і. Іgnatieva
GGG.L. Gumeniuk
G.L. Gumeniuk
VSV.а. Svyatnenko
V.а. Svyatnenko
NBNatalia Bobok
Natalia Bobok
BACKGROUND. In patients with widespread pulmonary tuberculosis, the disease with pronounced symptoms of intoxication may be due to the disruption of protein metabolism and the function of the hepatobiliary system, and thus, a decrease in the level of amino acids in the liver, protein, substituted for ammonia, indicators of ALT, AST, thymol test. Changing biochemical test results to confirm the presence of hepatotoxic, cholestatic or mixed side effects of antimycobacterial drugs. Their influx into the development of osteoporosis without surviving, behind the blame of lonely work twenty years ago. In connection with this, diagnosis and treatment of the dynamics of disruption of mineral metabolism of bone tissue in patients with drugresistant tuberculosis based on computed tomography (CT) data of the chest organs are relevant. OBJECTIVE. To monitor the dynamics of mineral thickness of bone tissue of the spine and the development of osteoporosis in patients with drug-resistant tuberculosis according to CT of the chest organs and demonstrate on clinical butts. MATERIALS AND METHODS. Densitometry was carried out using the K-Pacs program. The results were compared with the results of diagnosing osteoporosis based on the standardized 3D QCT program. 38 patients with drug-resistant pulmonary tuberculosis were analyzed in the dynamics of CT of the chest organs, in which monitoring of the structure (Th12, L1-L2) of the ridges was carried out for the lowest values of densitometric indicators (average, minimum and maximum bone mineral density) on axial CT sections. Control examination of the bone mineral density was carried out 1 time after the cob. RESULTS. With post-operative release, 39.5 % of patients had a decrease in densitometric indicators of the vertebrae (osteopenia and osteoporosis). During the control fasting after 1 year of the cob, 92.1 % of patients experienced a decrease in densitometric readings, which indicates a decrease in spine metabolism. CONCLUSIONS. The use of CT data of the chest organs for diagnosing disorders of mineral metabolism in bone tissue of the spine in patients with pulmonary tuberculosis is an accessible and informative method.